PortfoliosLab logo
Cortexyme Inc (QNCX)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

IPO Date

May 9, 2019

Highlights

Market Cap

$48.54M

EPS (TTM)

-$1.31

Total Revenue (TTM)

$168.00K

Gross Profit (TTM)

$40.00K

EBITDA (TTM)

-$27.35M

Year Range

$0.51 - $2.45

Target Price

$7.25

Short %

3.70%

Short Ratio

10.69

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
QNCX vs. DAL
Popular comparisons:

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Cortexyme Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%100.00%December2025FebruaryMarchAprilMay
-96.72%
95.22%
QNCX (Cortexyme Inc)
Benchmark (^GSPC)

Returns By Period

Cortexyme Inc (QNCX) returned -42.25% year-to-date (YTD) and 8.72% over the past 12 months.


QNCX

YTD

-42.25%

1M

-14.96%

6M

-33.33%

1Y

8.72%

5Y*

-52.57%

10Y*

N/A

^GSPC (Benchmark)

YTD

-4.72%

1M

-0.51%

6M

-1.78%

1Y

11.67%

5Y*

14.69%

10Y*

10.26%

*Annualized

Monthly Returns

The table below presents the monthly returns of QNCX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-13.90%-9.94%-8.28%-17.29%-1.82%-42.25%
202418.10%4.84%-18.46%0.94%-22.43%-9.64%-0.01%-7.85%12.33%108.71%26.54%-8.78%78.10%
202353.85%-5.31%68.10%-1.92%-1.96%0.33%-20.27%9.17%-14.50%-13.30%-8.34%17.98%64.84%
2022-51.82%-28.45%42.30%-40.87%-29.23%-14.29%-12.16%-9.74%-24.43%-24.81%-26.30%-13.57%-94.95%
202141.18%-13.13%5.75%8.71%5.62%28.11%6.62%70.41%-4.82%-85.60%-1.44%-3.00%-54.57%
2020-16.30%6.94%-9.23%0.02%1.03%0.46%-13.93%10.34%13.71%-4.26%1.52%-42.84%-50.52%
2019-21.95%65.60%-16.73%-43.93%25.59%-16.69%26.38%113.87%70.69%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of QNCX is 55, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of QNCX is 5555
Overall Rank
The Sharpe Ratio Rank of QNCX is 5252
Sharpe Ratio Rank
The Sortino Ratio Rank of QNCX is 6060
Sortino Ratio Rank
The Omega Ratio Rank of QNCX is 5757
Omega Ratio Rank
The Calmar Ratio Rank of QNCX is 5353
Calmar Ratio Rank
The Martin Ratio Rank of QNCX is 5252
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Cortexyme Inc (QNCX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The chart of Sharpe ratio for QNCX, currently valued at 0.03, compared to the broader market-2.00-1.000.001.002.003.00
QNCX: 0.03
^GSPC: 0.49
The chart of Sortino ratio for QNCX, currently valued at 0.79, compared to the broader market-6.00-4.00-2.000.002.004.00
QNCX: 0.79
^GSPC: 0.81
The chart of Omega ratio for QNCX, currently valued at 1.09, compared to the broader market0.501.001.502.00
QNCX: 1.09
^GSPC: 1.12
The chart of Calmar ratio for QNCX, currently valued at 0.02, compared to the broader market0.001.002.003.004.005.00
QNCX: 0.02
^GSPC: 0.50
The chart of Martin ratio for QNCX, currently valued at 0.08, compared to the broader market-10.000.0010.0020.00
QNCX: 0.08
^GSPC: 2.00

The current Cortexyme Inc Sharpe ratio is 0.03. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Cortexyme Inc with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00December2025FebruaryMarchAprilMay
0.03
0.49
QNCX (Cortexyme Inc)
Benchmark (^GSPC)

Dividends

Dividend History


Cortexyme Inc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2025FebruaryMarchAprilMay
-99.10%
-8.79%
QNCX (Cortexyme Inc)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Cortexyme Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Cortexyme Inc was 99.55%, occurring on Aug 15, 2024. The portfolio has not yet recovered.

The current Cortexyme Inc drawdown is 99.10%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.55%Aug 11, 2021758Aug 15, 2024
-61.69%Feb 18, 2020222Dec 31, 2020151Aug 9, 2021373
-56.16%Jul 2, 201943Aug 30, 201977Dec 19, 2019120
-38.11%Dec 24, 20199Jan 7, 202027Feb 14, 202036
-27.46%May 10, 20191May 10, 201925Jun 17, 201926

Volatility

Volatility Chart

The current Cortexyme Inc volatility is 21.17%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%December2025FebruaryMarchAprilMay
21.17%
14.11%
QNCX (Cortexyme Inc)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Cortexyme Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Cortexyme Inc, comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -183.9%.

-0.80-0.60-0.40-0.200.00AprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober
-0.28
-0.10
Actual
Estimate

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items